Vieser Jaime
SEC insider (Form 3/4/5 filer). CIK 0001846045. Director at Alaunos Therapeutics, Inc. (TCRT) and 2 other issuers. 16 reported Form 4/5 transactions since Sep 2024; latest on Oct 6, 2026. Located in FORT LAUDERDALE, FL.
Companies Vieser Jaime has filed insider reports for
- Alaunos Therapeutics, Inc. (TCRT): Director
- Mountain Lake Acquisition Corp. (MLAC): Director
- Mountain Lake Acquisition Corp. II (MLAA): Director
Vieser Jaime
CIK: 0001846045
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (16 total)
- Oct 6, 2026TCRT
Alaunos Therapeutics, Inc.
AwardDirect22.7K shares at avg. $0.74$17K - Jul 23, 2026TCRT
Alaunos Therapeutics, Inc.
AwardDirect8.8K shares at avg. $1.92$17K - Jun 11, 2026MLAC
Mountain Lake Acquisition Corp.
DispositionDirect478K shares- - Jun 11, 2026MLAC
Mountain Lake Acquisition Corp.
ExerciseDirectClass B ordinary shares, par value $0.0001 per share
478K shares- - Jun 1, 2026MLAC
Mountain Lake Acquisition Corp.
OtherDirectClass B ordinary shares, par value $0.0001 per share
478K shares- - Apr 29, 2026TCRT
Alaunos Therapeutics, Inc.
AwardDirect6.5K shares at avg. $2.59$17K - Jan 12, 2026TCRT
Alaunos Therapeutics, Inc.
AwardDirect5.8K shares at avg. $2.89$17K - Nov 21, 2025TCRT
Alaunos Therapeutics, Inc.
AwardDirect5.3K shares at avg. $3.16$17K - Jul 3, 2025TCRT
Alaunos Therapeutics, Inc.
AwardDirect3.4K shares- - Jun 24, 2025TCRT
Alaunos Therapeutics, Inc.
PurchaseDirectSeries A-2 Convertible Preferred Stock
250 shares at avg. $4.49-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 6, 2026 |  TCRT Alaunos Therapeutics, Inc. | Award | 22,669 | $0.74 | $16,875 | Direct |
| Jul 23, 2026 | TCRT Alaunos Therapeutics, Inc. | Award | 8,789 | $1.92 | $16,875 | Direct |
| Jun 11, 2026 |  MLAC Mountain Lake Acquisition Corp. | Disposition | 478,010 | - | $0 | Direct |
| Jun 11, 2026 | MLAC Mountain Lake Acquisition Corp. | Exercise Class B ordinary shares, par value $0.0001 per share | 478,010 | - | - | Direct |
| Jun 1, 2026 | MLAC Mountain Lake Acquisition Corp. | Other Class B ordinary shares, par value $0.0001 per share | 478,010 | - | - | Direct |
| Apr 29, 2026 | TCRT Alaunos Therapeutics, Inc. | Award | 6,515 | $2.59 | $16,874 | Direct |
| Jan 12, 2026 | TCRT Alaunos Therapeutics, Inc. | Award | 5,839 | $2.89 | $16,875 | Direct |
| Nov 21, 2025 | TCRT Alaunos Therapeutics, Inc. | Award | 5,340 | $3.16 | $16,874 | Direct |
| Jul 3, 2025 | TCRT Alaunos Therapeutics, Inc. | Award | 3,400 | - | - | Direct |
| Jun 24, 2025 | TCRT Alaunos Therapeutics, Inc. | Purchase Series A-2 Convertible Preferred Stock | 250 | $4.49 | - | Direct |
1-10 of 16 transactions